Mylotarg and venoocclusive liver disease 
Mylotarg and venoocclusive liver disease Patient Reports February 12, 2012
Mylotarg Side Effects Report #5226095-3
Mylotarg side effect was reported by a Physician from JAPAN on Jan 23, 2007. Male patient, weighting 163.1 lb, was diagnosed with t-cell type acute leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: neutropenia, performance status decreased, pleurisy, pneumonia
, venoocclusive liver disease, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with BACTRIM, ACINON, ASPARTATE CALCIUM, VITAJECT, ALFAROL, FRAGMIN. Patient was hospitalized. Patient died on 08/24/2006.Mylotarg Side Effects Report #5344325-4
Mylotarg side effect was reported by a Physician from JAPAN on May 25, 2007. Male patient, weighting 163.1 lb, was diagnosed with t-cell type acute leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: multi-organ failure, neutropenia, performance status decreased, pleurisy, pneumonia
, venoocclusive liver disease, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with BAKTAR, ACINON, ASPARTATE CALCIUM, VITAJECT, ALFAROL, FRAGMIN. Patient was hospitalized. Patient died on 08/24/2006.Mylotarg Side Effects Report #4923871-9
Mylotarg side effect was reported by a Pharmacist from UNITED STATES on Feb 24, 2006. Male patient, weighting 189.6 lb, was diagnosed with leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Mylotarg dosage: 18 MG DAY 1 IV. During the same period patient was treated with URSODIOL, AMITRIPTYLINE, FLUCONAZOLE, CIPRO, PROTONIX, VANCOMYCIN, CEFEPIME. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5806904-7
Mylotarg side effect was reported by a Physician from TURKEY on June 29, 2008. Male patient, 14 years of age, was diagnosed with leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: chills, pyrexia, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with HEPARIN. Patient died.
Mylotarg Side Effects Report #4620344-8
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 15, 2005. Female patient, 70 years of age, weighting 200.2 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: coagulopathy, corynebacterium infection, culture urine positive, hypoglycaemia, pancytopenia, renal failure acute, sepsis
, venoocclusive liver disease. Mylotarg dosage: 18 MG 1 X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ZANTAC, ACYCLOVIR, LEVOTHYROXINE, DIFLUCAN. Patient was hospitalized. Patient died on 02/20/2005.Mylotarg Side Effects Report #5081982-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on July 31, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood potassium decreased, blood urea increased, performance status decreased, petechiae, platelet count decreased, sepsis
, venoocclusive liver disease, white blood cell count decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, DIFLUCAN, CLARITHROMYCIN, FAMOTIDINE, MUCOSTA, FEPRAZONE. Patient was hospitalized. Patient died.Mylotarg Side Effects Report #5113465-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 08, 2006. Male patient, 59 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, central line infection, fibrin degradation products increased, sepsis
, venoocclusive liver disease, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with ENOCITABINE, ETOPOSIDE, NOVANTRONE, LEVOFLOXACIN, ITRACONAZOLE, ALLOPURINOL, FAMOTIDINE, SUCRALFATE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4866377-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 13, 2005. Male patient, 59 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: hepatitis
, pyrexia, venoocclusive liver disease, weight increased. Mylotarg dosage: 16 MG 1X PER 1 DAY. Patient recovered.Mylotarg Side Effects Report #4928140-9
Mylotarg side effect was reported by a Health Professional from JAPAN on Feb 09, 2006. Male patient, 59 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, dehydration, hepatitis
, hiccups, interstitial lung disease, venoocclusive liver disease, viral infection , weight increased. Mylotarg dosage: 16 MG (9 MG/M2/DAY) INTRAVENOUS DRIP. During the same period patient was treated with MEROPEN, AMIKACIN SULPHATE, FUNGUARD, LEUKOPROL. Patient recovered.Mylotarg Side Effects Report #4941620-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 23, 2006. Male patient, 59 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: dehydration, hepatitis
, hiccups, interstitial lung disease, neutrophil percentage decreased, venoocclusive liver disease, weight increased. Mylotarg dosage: 16 MG (9 MG/M2/DAY) INTRAVENOUS DRIP. During the same period patient was treated with MEROPEN, AMIKACIN SULPHATE, FUNGUARD, TIENAM. Patient recovered.Mylotarg Side Effects Report #5002570-1
Mylotarg side effect was reported by a Physician from JAPAN on Apr 27, 2006. Male patient, 59 years of age, was diagnosed with acute myeloid leukaemia recurrent, bacterial infection
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain , anorexia, fibrin degradation products increased, hepatitis , hiccups, interstitial lung disease, neutropenic infection, venoocclusive liver disease, weight increased. Mylotarg dosage: 16 MG (9 MG/M2/DAY) INTRAVENOUS DRIP. During the same period patient was treated with VFEND, MEROPEN, AMIKACIN SULPHATE, FUNGUARD, LEUKOPROL, TIENAM, OZEX, SULFAMETHOXAZOLE. Patient recovered.Mylotarg Side Effects Report #5025813-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 31, 2006. Male patient, 59 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood albumin increased, central line infection, fibrin degradation products increased, hepatic function abnormal, sepsis
, venoocclusive liver disease, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with LEVOFLOXACIN, ITRACONAZOLE, ALLOPURINOL, FAMOTIDINE, SUCRALFATE, BIOFERMIN R, URSO, BICARBONATE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4837022-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 07, 2005. Female patient, 55 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, disease progression, hepatomegaly, leukaemia, pyrexia, sepsis
, venoocclusive liver disease. Mylotarg dosage: A SINGLE 6MG/M2 DOSE. During the same period patient was treated with CARBENIN, ISEPACIN, MAXIPIME, AMIKACIN SULPHATE, PRODIF, ALBUMIN, ANTITHROMBIN III. Patient recovered.Mylotarg Side Effects Report #4887455-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 10, 2006. Female patient, 55 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, disease progression, sepsis
, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with CARBENIN, MAXIPIME, AMIKACIN SULPHATE, PRODIF, ALBUMIN, ANTITROMBIN III. Patient was hospitalized and became disabled. Patient recovered.Mylotarg Side Effects Report #5244326-0
Mylotarg side effect was reported by a Physician from JAPAN on Feb 15, 2007. Male patient, 45 years of age, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: pneumonia
, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with LASIX, VANCOMYCIN HYDROCHLORIDE, FUNGUARD. Patient died on 08/23/2006.Mylotarg Side Effects Report #5110875-9
Mylotarg side effect was reported by a Health Professional from JAPAN on Sept 11, 2006. Male patient, 45 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: pneumonia
, venoocclusive liver disease, weight increased, white blood cell count decreased. Mylotarg dosage: 9MG/M^2 1X PER 1 DAY; INTRAVENOUS DRIP. During the same period patient was treated with VANCOCIN, FUNGUARD, LASIX, VFEND. Patient died.Mylotarg Side Effects Report #5242939-3
Mylotarg side effect was reported by a Physician from JAPAN on Feb 09, 2007. Female patient, 37 years of age, weighting 97.00 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: thrombotic microangiopathy, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with HEPARIN ECTION, FUNGUARD, BUSULFAN, OMEPRAL. Patient died on 06/21/2006.
Mylotarg Side Effects Report #5283746-5
Mylotarg side effect was reported by a Physician from JAPAN on Mar 23, 2007. Female patient, 37 years of age, weighting 97.00 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: thrombotic microangiopathy, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with HEPARIN, FUNGUARD, BUSULFAN, OMEPRAL. Patient died on 06/21/2006.
Mylotarg Side Effects Report #5342340-8
Mylotarg side effect was reported by a Physician from JAPAN on Mar 23, 2007. Female patient, 37 years of age, weighting 97.00 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: thrombotic microangiopathy, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with HEPARIN, FUNGUARD, BUSULFAN, URSO, OMEPRAL. Patient died on 06/21/2006.
Mylotarg Side Effects Report #5806906-0
Mylotarg side effect was reported by a Physician from TURKEY on June 29, 2008. Male patient, 20 years of age, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: chills, pyrexia, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with HEPARIN. Patient recovered.
Mylotarg Side Effects Report #5268144-2
Mylotarg side effect was reported by a Physician from JAPAN on Mar 08, 2007. Female patient, weighting 130.1 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, lung injury, mouth haemorrhage, platelet count decreased, pseudomonal sepsis, venoocclusive liver disease, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with HYDREA, SULPERAZON, HEPARIN, FUNGUARD, ZOVIRAX, DAUNORUBICIN HYDROCHLORIDE, TOBRACIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5348171-7
Mylotarg side effect was reported by a Physician from JAPAN on May 25, 2007. Male patient, weighting 119.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: pneumonia
, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with GASTER, DIFLUCAN, LEVOFLOXACIN, LASIX, SELBEX. Patient died on 03/27/2007.Mylotarg Side Effects Report #5397497-X
Mylotarg side effect was reported by a Physician from JAPAN on July 19, 2007. Female patient, weighting 101.4 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, febrile neutropenia, sepsis
, venoocclusive liver disease. Mylotarg dosage: unknown. Patient died on 06/01/2007.Mylotarg Side Effects Report #5403081-1
Mylotarg side effect was reported by a Physician from JAPAN on July 30, 2007. Male patient, weighting 119.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: pneumonia
, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with FAMOTIDINE, DIFLUCAN, LEVOFLOXACIN, LASIX, SELBEX. Patient died on 03/27/2007.Mylotarg Side Effects Report #5458523-2
Mylotarg side effect was reported by a Physician from JAPAN on Sept 12, 2007. Female patient, weighting 101.4 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, sepsis
, venoocclusive liver disease. Mylotarg dosage: unknown. Patient died on 06/01/2007.Mylotarg Side Effects Report #5563271-4
Mylotarg side effect was reported by a Physician from JAPAN on Dec 12, 2007. Female patient, weighting 110.2 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, pulmonary alveolar haemorrhage, sepsis
, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with BIOFERMIN, ITRIZOLE, BAKTAR, GASTER, ASPARA K. Patient died on 11/18/2006.Mylotarg Side Effects Report #5649066-1
Mylotarg side effect was reported by a Physician from JAPAN on Feb 26, 2008. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, bacteraemia, febrile neutropenia, venoocclusive liver disease, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, DIFLUCAN, FLUVOXAMINE MALEATE, DEPAS, ZANTAC, AMOBAN, MAGNESIUM OXIDE, GLYSENNID. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5725096-6
Mylotarg side effect was reported by a Physician from JAPAN on Apr 23, 2008. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, bacteraemia, febrile neutropenia, venoocclusive liver disease, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, DIFLUCAN, FLUVOXAMINE MALEATE, DEPAS, ZANTAC, AMOBAN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5758249-1
Mylotarg side effect was reported by a Physician from JAPAN on May 29, 2008. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cytomegalovirus enterocolitis, graft versus host disease, sepsis
, venoocclusive liver disease. Mylotarg dosage: unknown. Patient recovered.Mylotarg Side Effects Report #6057731-X
Mylotarg side effect was reported by a Physician from JAPAN on Jan 21, 2009. Female patient, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia recurrent, sepsis
, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, neutrophil count decreased, platelet count decreased, sepsis , venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with MODACIN, ITRIZOLE, GASTER, ZOVIRAX, COTRIM. Patient recovered.Mylotarg Side Effects Report #4725795-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 14, 2005. Male patient, 81 years of age, weighting 136.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatine increased, respiratory failure, venoocclusive liver disease, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #4929810-9
Mylotarg side effect was reported by a Physician from UNITED STATES on Feb 13, 2006. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Mylotarg dosage: unknown. Patient recovered.
Mylotarg Side Effects Report #4603884-7
Mylotarg side effect was reported by a Consumer or non-health professional from on Feb 24, 2005. Male patient, 69 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: diarrhoea, hepatic function abnormal, neutropenia, portal vein thrombosis, pyrexia, renal impairment, venoocclusive liver disease, vomiting. Mylotarg dosage: 9 MG/M^1X PER 1 DAY, INTRAVENOUS. Patient died.
Mylotarg Side Effects Report #5073619-5
Mylotarg side effect was reported by a Physician from UNITED STATES on July 25, 2006. Male patient, 68 years of age, weighting 133.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: hepatic vein thrombosis, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE. Patient recovered.
Mylotarg Side Effects Report #4678767-7
Mylotarg side effect was reported by a Pharmacist from on May 24, 2005. Male patient, 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Mylotarg dosage: 9 MG/M2 TIMES TWO DOSES, INTRAVENOUS. Patient died on 05/17/2005.
Mylotarg Side Effects Report #4684610-2
Mylotarg side effect was reported by a Pharmacist from on May 26, 2005. Male patient, 64 years of age, weighting 168.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. Patient died on 05/17/2005.
Mylotarg Side Effects Report #5092323-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2006. Female patient, 60 years of age, weighting 163.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Mylotarg dosage: A SINGLE 11 MG DOSE, INTRAVENOUS. Patient recovered.
Mylotarg Side Effects Report #4645987-7
Mylotarg side effect was reported by a Consumer or non-health professional from on Apr 13, 2005. Female patient, 60 years of age, weighting 163.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: pyrexia, venoocclusive liver disease. Mylotarg dosage: A SINGLE 11 MG DOSE, INTRAVENOUS. Patient recovered.
Mylotarg Side Effects Report #5006870-0
Mylotarg side effect was reported by a Health Professional from UNITED STATES on May 05, 2006. Female patient, 60 years of age, weighting 163.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, venoocclusive liver disease. Mylotarg dosage: A SINGLE 11 MG DOSE, INTRAVENOUS. Patient recovered.
Mylotarg Side Effects Report #4899234-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 18, 2006. Male patient, 59 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: dehydration, hepatitis
, hiccups, venoocclusive liver disease, weight increased. Mylotarg dosage: 16 MG (9 MG/M2/DAY), INTRAVENOUS DRIP. During the same period patient was treated with MEROPEN, AMIKACIN SULPHATE, FUNGUARD. Patient recovered.Mylotarg Side Effects Report #5053177-1
Mylotarg side effect was reported by a Health Professional from UNITED STATES on June 29, 2006. Female patient, 55 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: pneumonia
, venoocclusive liver disease, weight increased. Mylotarg dosage: 9.3 MG 1X PER 1 DAY; INTRAVENOUS. Patient recovered.Mylotarg Side Effects Report #5136054-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2006. Female patient, 55 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, febrile neutropenia, pleural effusion, pneumonia
, venoocclusive liver disease, weight increased. Mylotarg dosage: 9.3 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with VORICONAZOLE, VANCOMYCIN, LEVOFLOXACIN, CEFEPIME, POTASSIUM CHLORIDE, NEUPOGEN, DEXAMETHASONE, METRONIDAZOLE. Patient recovered.Mylotarg Side Effects Report #4825237-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 01, 2005. Female patient, 55 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Mylotarg dosage: A SINGLE 7 MG DOSE INTRAVENOUS DRIP; A SINGLE 5MG DOSE INTRAVENOUS DRIP. Patient died.
Mylotarg Side Effects Report #5023602-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 25, 2006. Female patient, 55 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, condition aggravated, disease progression, disseminated intravascular coagulation, pyrexia, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with CARBENIN, MAXIPIME, AMIKACIN SULPHATE, PRODIF, ANTITHROMBIN III, FRAGMIN. Patient recovered.
Mylotarg Side Effects Report #6094040-7
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Feb 20, 2009. Male patient, 51 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: chronic sinusitis, deafness neurosensory, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with DACOGEN. Patient recovered.
Mylotarg Side Effects Report #5453995-1
Mylotarg side effect was reported by a Physician from UNITED STATES on Sept 07, 2007. Female patient, 49 years of age, weighting 134.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: liver disorder, venoocclusive liver disease. Mylotarg dosage: 6 MG/M2 (9 MG TOTAL DOSE ADMINISTERED). During the same period patient was treated with DAUNOMYCIN, CYTARABINE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5475867-9
Mylotarg side effect was reported by a Physician from UNITED STATES on Sept 24, 2007. Female patient, 49 years of age, weighting 134.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: liver disorder, venoocclusive liver disease. Mylotarg dosage: 6 MG/M2 (9 MG TOTAL DOSE ADMINISTERED). During the same period patient was treated with DAUNOMYCIN, CYTARABINE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5660827-5
Mylotarg side effect was reported by a Physician from UNITED STATES on Feb 29, 2008. Female patient, 49 years of age, weighting 134.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: liver disorder, venoocclusive liver disease. Mylotarg dosage: 6 MG/M2 (9 MG TOTAL DOSE ADMINISTERED). During the same period patient was treated with DAUNOMYCIN, CYTARABINE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4937492-5
Mylotarg side effect was reported by a Pharmacist from UNITED STATES on Feb 23, 2006. Male patient, 43 years of age, weighting 189.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: portal hypertension, venoocclusive liver disease. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with URSODIOL, NORTRIPTYLINE, FLUCONAZOLE, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4718686-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2005. Male patient, 37 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood uric acid increased, neutropenia, venoocclusive liver disease. Mylotarg dosage: 6 MG/M^2 PER 1 DAY, INTRAVNEOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4957704-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2006. Male patient, 26 years of age, weighting 223.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain
, alanine aminotransferase increased, bacteraemia, lethargy, nausea , venoocclusive liver disease. Mylotarg dosage: 14 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with BUSULFAN, DAUNOMYCIN, NEUPOGEN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5533309-9
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Nov 26, 2007. Male patient, 24 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Mylotarg dosage: unknown. Patient died.
Mylotarg Side Effects Report #5806903-5
Mylotarg side effect was reported by a Physician from TURKEY on June 29, 2008. Male patient, child 2 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bone marrow failure, chills, pyrexia, venoocclusive liver disease. Mylotarg dosage: unknown. Patient died.
Mylotarg Side Effects Report #5511713-2
Mylotarg side effect was reported by a Physician from JAPAN on Nov 01, 2007. Male patient, weighting 145.5 lb, was diagnosed with acute myeloid leukaemia, prophylaxis, pyrexia, insomnia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood sodium increased, diarrhoea, gastrointestinal infection, neutrophil count decreased, petechiae, platelet count decreased, venoocclusive liver disease, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with ADALAT, DIFLUCAN, PN TWIN, ZANTAC, ZYVOX, SILECE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5584230-1
Mylotarg side effect was reported by a Physician from JAPAN on Dec 25, 2007. Female patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia, neutropenia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, hyperbilirubinaemia, neurogenic bladder, pneumonia
, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with PREDONINE, VANCOMYCIN, MEROPENEM, AMBISOME. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5585233-3
Mylotarg side effect was reported by a Physician from JAPAN on Jan 07, 2008. Female patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia, neutropenia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, neurogenic bladder, pneumonia
, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with PREDONINE, VANCOMYCIN, MEROPENEM, AMBISOME. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5633436-1
Mylotarg side effect was reported by a Physician from JAPAN on Feb 15, 2008. Female patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia, neutropenia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, neurogenic bladder, pneumonia
, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with PREDONINE, VANCOMYCIN, MEROPENEM, AMBISOME. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5723037-9
Mylotarg side effect was reported by a Physician from JAPAN on Apr 23, 2008. Male patient, weighting 147.7 lb, was diagnosed with acute myeloid leukaemia, endotracheal intubation, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: febrile neutropenia, pulmonary alveolar haemorrhage, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with ADONA, ROPION, TRANSAMIN, MIDAZOLAM, PRODIF, HYDROCORTONE, TARGOCID. Patient recovered.
Mylotarg Side Effects Report #5781375-8
Mylotarg side effect was reported by a Physician from JAPAN on June 17, 2008. Male patient, weighting 147.7 lb, was diagnosed with acute myeloid leukaemia, endotracheal intubation, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: condition aggravated, febrile neutropenia, pulmonary alveolar haemorrhage, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with ADONA, ROPION, TRANSAMIN, MIDAZOLAM, PRODIF, HYDROCORTONE, TARGOCID. Patient recovered.
Mylotarg Side Effects Report #6073135-8
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Feb 03, 2009. Female patient was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Mylotarg dosage: unknown. Patient recovered.
Mylotarg Side Effects Report #4678746-X
Mylotarg side effect was reported by a Pharmacist from on May 24, 2005. Male patient was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: hepatic failure, renal failure, venoocclusive liver disease. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. Patient died on 05/18/2005.
Mylotarg Side Effects Report #5020575-1
Mylotarg side effect was reported by a Physician from UNITED STATES on May 24, 2006. Male patient was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with ANTINEOPLASTIC AGENT. Patient recovered.
Mylotarg Side Effects Report #5316705-4
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Apr 24, 2007. Male patient, 79 years of age, was treated with Mylotarg. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Mylotarg dosage: 9 MG/M2 (FEQUENCY NOT SPECIFIED). Patient recovered.
Mylotarg Side Effects Report #5358372-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 13, 2007. Male patient, weighting 257.9 lb, was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, coagulopathy, fibrin d dimer increased, liver tenderness, prothrombin time prolonged, thrombocytopenia, venoocclusive liver disease. Mylotarg dosage: 13.8 MG. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5195785-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 27, 2006. Male patient, weighting 156.7 lb, was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, venoocclusive disease, venoocclusive liver disease. Mylotarg dosage: 11 MG. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient recovered.